Marc Louis Copersino, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroconvulsive Therapy | 2 | 2023 | 500 | 1.130 |
Why?
|
| Psychotherapy, Group | 2 | 2023 | 412 | 0.970 |
Why?
|
| Marijuana Abuse | 7 | 2013 | 410 | 0.940 |
Why?
|
| Substance Withdrawal Syndrome | 8 | 2011 | 623 | 0.830 |
Why?
|
| Cocaine-Related Disorders | 10 | 2010 | 461 | 0.810 |
Why?
|
| Substance-Related Disorders | 12 | 2022 | 4404 | 0.740 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 4744 | 0.480 |
Why?
|
| Corpus Striatum | 1 | 2019 | 1233 | 0.430 |
Why?
|
| Disabled Persons | 1 | 2022 | 1224 | 0.400 |
Why?
|
| Cognition Disorders | 4 | 2012 | 3975 | 0.370 |
Why?
|
| Needle Sharing | 1 | 2009 | 22 | 0.340 |
Why?
|
| Anterior Cerebral Artery | 1 | 2009 | 50 | 0.320 |
Why?
|
| Unsafe Sex | 1 | 2009 | 238 | 0.290 |
Why?
|
| Middle Cerebral Artery | 1 | 2009 | 275 | 0.290 |
Why?
|
| Marijuana Smoking | 1 | 2010 | 258 | 0.280 |
Why?
|
| Substance Abuse Treatment Centers | 5 | 2007 | 166 | 0.260 |
Why?
|
| Age Factors | 5 | 2019 | 18326 | 0.260 |
Why?
|
| Neuropsychological Tests | 5 | 2012 | 7024 | 0.240 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2009 | 529 | 0.240 |
Why?
|
| Methadone | 5 | 2014 | 320 | 0.240 |
Why?
|
| Color Perception | 2 | 2007 | 212 | 0.240 |
Why?
|
| Self Care | 2 | 2006 | 793 | 0.220 |
Why?
|
| Risk-Taking | 1 | 2009 | 1033 | 0.220 |
Why?
|
| Cannabinoids | 1 | 2006 | 172 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2012 | 3165 | 0.220 |
Why?
|
| Receptors, Opioid, mu | 3 | 2010 | 166 | 0.210 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2003 | 67 | 0.210 |
Why?
|
| Alcoholism | 5 | 2007 | 1965 | 0.210 |
Why?
|
| Cocaine | 6 | 2010 | 958 | 0.210 |
Why?
|
| Schizophrenic Psychology | 3 | 2004 | 1646 | 0.200 |
Why?
|
| Behavior, Addictive | 2 | 2022 | 462 | 0.190 |
Why?
|
| Reading | 1 | 2004 | 529 | 0.180 |
Why?
|
| Semantics | 1 | 2004 | 601 | 0.180 |
Why?
|
| Psychological Tests | 1 | 2003 | 639 | 0.180 |
Why?
|
| Heroin Dependence | 3 | 2010 | 172 | 0.170 |
Why?
|
| Cognition | 4 | 2023 | 6952 | 0.160 |
Why?
|
| Cerebrovascular Circulation | 1 | 2009 | 2725 | 0.160 |
Why?
|
| Attention | 3 | 2007 | 2387 | 0.150 |
Why?
|
| Adult | 32 | 2023 | 219725 | 0.140 |
Why?
|
| Motivation | 5 | 2013 | 1996 | 0.140 |
Why?
|
| Token Economy | 2 | 2006 | 17 | 0.130 |
Why?
|
| Secondary Prevention | 1 | 2022 | 1474 | 0.130 |
Why?
|
| Reaction Time | 3 | 2014 | 2076 | 0.120 |
Why?
|
| Cannabis | 2 | 2011 | 436 | 0.120 |
Why?
|
| Organ Size | 1 | 2019 | 2248 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 3 | 2007 | 1176 | 0.110 |
Why?
|
| Electroencephalography | 1 | 2009 | 6187 | 0.110 |
Why?
|
| Psychotropic Drugs | 3 | 2007 | 883 | 0.110 |
Why?
|
| Mass Screening | 3 | 2009 | 5412 | 0.100 |
Why?
|
| Prescription Drugs | 2 | 2010 | 626 | 0.100 |
Why?
|
| Narcotics | 3 | 2007 | 336 | 0.090 |
Why?
|
| Humans | 39 | 2023 | 757566 | 0.090 |
Why?
|
| Geriatric Assessment | 1 | 2018 | 1402 | 0.090 |
Why?
|
| Schizophrenia | 3 | 2004 | 6911 | 0.090 |
Why?
|
| Male | 31 | 2019 | 358180 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 6014 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2023 | 8550 | 0.090 |
Why?
|
| Recurrence | 5 | 2013 | 8426 | 0.080 |
Why?
|
| Opiate Substitution Treatment | 1 | 2014 | 436 | 0.080 |
Why?
|
| Brain | 4 | 2010 | 26952 | 0.080 |
Why?
|
| Fentanyl | 3 | 2010 | 434 | 0.080 |
Why?
|
| Heroin | 1 | 2010 | 119 | 0.080 |
Why?
|
| Comorbidity | 5 | 2007 | 10477 | 0.080 |
Why?
|
| Female | 30 | 2019 | 389943 | 0.080 |
Why?
|
| Self Disclosure | 1 | 2009 | 249 | 0.080 |
Why?
|
| Fourier Analysis | 1 | 2009 | 440 | 0.070 |
Why?
|
| Psychomotor Performance | 2 | 2014 | 1878 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2023 | 64242 | 0.070 |
Why?
|
| Analysis of Variance | 4 | 2011 | 6230 | 0.070 |
Why?
|
| Computational Biology | 1 | 2019 | 3501 | 0.070 |
Why?
|
| ROC Curve | 2 | 2018 | 3562 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2009 | 280 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2013 | 2357 | 0.070 |
Why?
|
| Tranquilizing Agents | 1 | 2006 | 58 | 0.060 |
Why?
|
| Middle Aged | 18 | 2018 | 219192 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2018 | 3726 | 0.060 |
Why?
|
| Verbal Behavior | 1 | 2007 | 335 | 0.060 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2007 | 415 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 1370 | 0.060 |
Why?
|
| Trauma Centers | 2 | 2007 | 933 | 0.060 |
Why?
|
| Clinical Trials as Topic | 3 | 2010 | 7982 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2013 | 2024 | 0.060 |
Why?
|
| Wounds and Injuries | 2 | 2007 | 2475 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2922 | 0.060 |
Why?
|
| Behavior Therapy | 2 | 2007 | 869 | 0.060 |
Why?
|
| Opioid-Related Disorders | 4 | 2010 | 2141 | 0.060 |
Why?
|
| Analgesics, Opioid | 3 | 2010 | 3762 | 0.050 |
Why?
|
| Discrimination Learning | 1 | 2004 | 278 | 0.050 |
Why?
|
| Culture | 1 | 2007 | 623 | 0.050 |
Why?
|
| HIV Infections | 1 | 2009 | 17270 | 0.050 |
Why?
|
| Disease Progression | 1 | 2019 | 13463 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2008 | 1011 | 0.050 |
Why?
|
| Depression | 1 | 2021 | 8049 | 0.050 |
Why?
|
| Coffee | 1 | 2006 | 582 | 0.050 |
Why?
|
| Cues | 1 | 2007 | 869 | 0.050 |
Why?
|
| Sex Factors | 3 | 2010 | 10495 | 0.050 |
Why?
|
| Verbal Learning | 2 | 2000 | 463 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 14637 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2006 | 14473 | 0.040 |
Why?
|
| Health Surveys | 1 | 2009 | 4056 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2022 | 828 | 0.040 |
Why?
|
| Smoking | 2 | 2006 | 9036 | 0.040 |
Why?
|
| Positron-Emission Tomography | 4 | 2010 | 6457 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 15207 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2006 | 1176 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2011 | 1988 | 0.040 |
Why?
|
| Ambulatory Care | 2 | 2007 | 2767 | 0.040 |
Why?
|
| Adolescent | 8 | 2018 | 87819 | 0.040 |
Why?
|
| Sickness Impact Profile | 1 | 2018 | 298 | 0.040 |
Why?
|
| Psychotherapy | 1 | 2005 | 1640 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2007 | 2505 | 0.030 |
Why?
|
| Baltimore | 2 | 2007 | 230 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 3670 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2008 | 6363 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 20037 | 0.030 |
Why?
|
| Social Desirability | 1 | 2013 | 46 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2007 | 303 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 3097 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 3864 | 0.030 |
Why?
|
| Substance Abuse Detection | 2 | 2006 | 301 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2006 | 4019 | 0.030 |
Why?
|
| United States | 5 | 2007 | 71902 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 25924 | 0.020 |
Why?
|
| Longevity | 1 | 2018 | 1050 | 0.020 |
Why?
|
| Socioeconomic Factors | 3 | 2011 | 7796 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2010 | 366 | 0.020 |
Why?
|
| Memory | 1 | 2000 | 2179 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10749 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2011 | 79984 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2010 | 225 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 2687 | 0.020 |
Why?
|
| Mental Disorders | 2 | 2007 | 6802 | 0.020 |
Why?
|
| Aged | 4 | 2018 | 167890 | 0.020 |
Why?
|
| Philosophy, Medical | 1 | 2007 | 79 | 0.020 |
Why?
|
| Self Concept | 1 | 2013 | 1041 | 0.020 |
Why?
|
| Linear Models | 2 | 2008 | 5856 | 0.020 |
Why?
|
| Young Adult | 4 | 2018 | 58755 | 0.020 |
Why?
|
| Residential Treatment | 1 | 2007 | 107 | 0.020 |
Why?
|
| Putamen | 1 | 2007 | 291 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2009 | 999 | 0.020 |
Why?
|
| Caudate Nucleus | 1 | 2007 | 389 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2013 | 1432 | 0.020 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2005 | 80 | 0.020 |
Why?
|
| Unemployment | 1 | 2007 | 208 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2007 | 564 | 0.020 |
Why?
|
| Protein Binding | 2 | 2008 | 9312 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 2005 | 458 | 0.010 |
Why?
|
| Accreditation | 1 | 2007 | 472 | 0.010 |
Why?
|
| Models, Organizational | 1 | 2007 | 546 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3415 | 0.010 |
Why?
|
| Professional Competence | 1 | 2007 | 430 | 0.010 |
Why?
|
| Mental Recall | 2 | 2000 | 1209 | 0.010 |
Why?
|
| Methamphetamine | 1 | 2005 | 165 | 0.010 |
Why?
|
| Alcohol-Related Disorders | 1 | 2006 | 235 | 0.010 |
Why?
|
| Long QT Syndrome | 1 | 2008 | 465 | 0.010 |
Why?
|
| Confidentiality | 1 | 2007 | 609 | 0.010 |
Why?
|
| Psychometrics | 2 | 2004 | 3051 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2010 | 2673 | 0.010 |
Why?
|
| Psychology | 1 | 2004 | 355 | 0.010 |
Why?
|
| Diffusion of Innovation | 1 | 2007 | 727 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2008 | 1419 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 706 | 0.010 |
Why?
|
| Professional-Patient Relations | 1 | 2007 | 726 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 2008 | 1688 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 15781 | 0.010 |
Why?
|
| Dopamine | 1 | 2007 | 1599 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2007 | 2425 | 0.010 |
Why?
|
| Serial Learning | 1 | 2000 | 42 | 0.010 |
Why?
|
| Mood Disorders | 1 | 2007 | 1123 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12261 | 0.010 |
Why?
|
| Prevalence | 2 | 2007 | 15640 | 0.010 |
Why?
|
| Ethanol | 1 | 2006 | 1324 | 0.010 |
Why?
|
| Forecasting | 1 | 2008 | 2919 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2009 | 6337 | 0.010 |
Why?
|
| Educational Status | 1 | 2007 | 2511 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58558 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2005 | 2252 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4235 | 0.010 |
Why?
|
| Data Collection | 1 | 2007 | 3319 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 2007 | 2167 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2008 | 39020 | 0.010 |
Why?
|
| Urban Population | 1 | 2004 | 2023 | 0.010 |
Why?
|
| Time Factors | 2 | 2008 | 39811 | 0.010 |
Why?
|
| Pain | 1 | 2010 | 5063 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12951 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2007 | 3579 | 0.010 |
Why?
|
| Anxiety | 1 | 2007 | 4532 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2006 | 3234 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 3970 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 36270 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2005 | 6571 | 0.010 |
Why?
|
| Acute Disease | 1 | 2000 | 7225 | 0.010 |
Why?
|
| Incidence | 1 | 2007 | 21217 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 8946 | 0.000 |
Why?
|
| Neurons | 1 | 2007 | 9418 | 0.000 |
Why?
|
| Hospitalization | 1 | 2007 | 10634 | 0.000 |
Why?
|
| Risk Factors | 1 | 2007 | 73708 | 0.000 |
Why?
|